Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Noritsu Koki Co., Ltd.

Capitalization 156B 1.04B 994M 925M 825M 1.47B 88.42B 1.62B 11.49B 4.26B 36.23B 3.92B 3.83B P/E ratio 2022
0.84x
P/E ratio 2023 10.8x
Enterprise value 128B 858M 818M 761M 679M 1.21B 72.74B 1.33B 9.45B 3.51B 29.81B 3.22B 3.15B EV / Sales 2022
0.54x
EV / Sales 2023 0.87x
Free-Float
50.39%
Yield 2022
1.76%
Yield 2023 3.84%
More valuation ratios * Estimated data
Dynamic Chart
MediPal Holdings Corporation completed the acquisition of PreMedica Inc. from Noritsu Koki Co., Ltd.. May. 30 CI
MediPal Holdings Corporation agreed to acquire PreMedica Inc. from Noritsu Koki Co., Ltd. for ¥3.8 billion. Apr. 29 CI
Noritsu Koki Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-05-12 CI
OMRON Corporation completed the acquisition of a 33% stake in JMDC Inc. from Noritsu Koki Co., Ltd.. 22-12-30 CI
Omron and JMDC Sign $973 Million Capital and Business Alliance Deal 22-02-23 MT
OMRON Corporation entered into a share transfer agreement to acquire 33% stake in JMDC Inc. from Noritsu Koki Co., Ltd. for ¥110 billion. 22-02-21 CI
Noritsu Koki Co., Ltd. completed the acquisition of JLab Audio, Inc. from Eagle Fund II, L.P. of Eagle Private Capital, LLC, Petra Growth Fund II, L.P. of Petra Capital Partners, LLC, PEAG Advisors, LLC and others. 21-05-05 CI
Noritsu Koki Co., Ltd. agreed to acquire JLab Audio, Inc. from Eagle Fund II, L.P. of Eagle Private Capital, LLC, Petra Growth Fund II, L.P. of Petra Capital Partners, LLC and others for ¥35 billion. 21-04-13 CI
Hikari Tsushin, Inc. completed the acquisition of NIHONKYOSAI Co., Ltd. from Noritsu Koki Co., Ltd.. 20-10-31 CI
AP67 Co., Ltd completed the acquisition of DENTAL Holding Corp. from Noritsu Koki Co., Ltd.. 20-08-31 CI
Eurofins Clinical Testing Holding LUX SARL completed the acquisition of GeneTech Inc. from Noritsu Koki Co., Ltd.. 20-08-31 CI
Eurofins Scientific : French group Eurofins signs deal to buy Japanese company GeneTech 20-08-07 RE
Eurofins Clinical Testing Holding LUX SARL entered into an agreement to acquire GeneTech Inc. from Noritsu Koki Co., Ltd.. 20-08-06 CI
More news
1 day+3.33%
1 week+3.56%
Current month+0.56%
1 month+18.09%
3 months+4.28%
6 months+6.12%
Current year+50.27%
More quotes
1 week
4 215.00
Extreme 4215
4 610.00
1 month
3 805.00
Extreme 3805
4 610.00
Current year
2 860.00
Extreme 2860
4 660.00
1 year
2 807.00
Extreme 2807
4 660.00
3 years
1 725.00
Extreme 1725
4 660.00
5 years
748.00
Extreme 748
4 660.00
10 years
370.00
Extreme 370
4 660.00
More quotes
Director TitleAgeSince
Chief Executive Officer 46 2018-05-31
Director of Finance/CFO 42 2015-05-31
Chief Administrative Officer - -
Manager TitleAgeSince
Director/Board Member 51 2015-06-28
Director/Board Member 71 2015-05-31
Director/Board Member 73 2015-05-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+3.33%+3.56%+49.67%+71.36%1.06B
-0.58%-3.97%+6.41%+3.43%5.93B
-0.75%-6.89%-3.86%-16.84%5.31B
-0.72%-4.72%-22.38%-40.17%3.85B
+1.96%-2.17%-18.31%-30.17%3.56B
+2.06%+1.68%-7.27%-53.67%3.42B
-3.69%-3.94%-18.13%-26.76%2.43B
-1.32%-2.60%-18.70%-52.68%1.83B
-0.91%-5.06%-13.30%-20.36%1.69B
+2.56%+2.56%+55.72%+57.64%1.29B
Average +0.19%-1.49%+0.98%-10.82% 3.04B
Weighted average by Cap. -0.07%-2.03%-4.43%-18.45%
See all sector performances

Financials

2022 2023
Net sales 73.52B 493M 470M 437M 390M 693M 41.76B 763M 5.43B 2.01B 17.11B 1.85B 1.81B 91.55B 614M 585M 544M 485M 864M 52.01B 950M 6.76B 2.51B 21.31B 2.31B 2.25B
Net income 102B 681M 649M 603M 538M 958M 57.69B 1.05B 7.5B 2.78B 23.64B 2.56B 2.5B 10.2B 68.37M 65.15M 60.61M 54.07M 96.2M 5.79B 106M 753M 279M 2.37B 257M 251M
Net Debt -45.36B -304M -290M -270M -240M -428M -25.77B -471M -3.35B -1.24B -10.56B -1.14B -1.12B -27.61B -185M -176M -164M -146M -260M -15.69B -287M -2.04B -756M -6.43B -695M -680M
More financial data * Estimated data
Logo Noritsu Koki Co., Ltd.
Noritsu Koki Co., Ltd. is a company principally engaged in the manufacturing business, healthcare business and other businesses. The Company operates in six business segments. The Manufacturing segment is engaged in the research, development and manufacture of pen nib parts and cosmetics materials, among others. The Healthcare segment is engaged in the research, development and sale of radiological business support services by remote diagnostic imaging in the healthcare area, the analysis of received data and the provision of survey data, among others. The Drug Discovery segment develops new products in biotechnology area. The Senior and Life segment conducts senior publishing and mail order sales business. The Agri-food segment conducts the production and sale of fresh vegetables in the agri-food field. The Others segment conducts new growth related survey and investment business.
Employees
1,246
Calendar
More about the company
Date Price Change Volume
24-12-02 4,505.00 ¥ +3.33% 85,800
24-12-02 4,360.00 ¥ -2.68% 136,300
24-11-29 4,480.00 ¥ +3.58% 357,400
24-11-28 4,325.00 ¥ +1.29% 75,600
24-11-27 4,270.00 ¥ -1.84% 109,200

Delayed Quote Japan Exchange, December 02, 2024 at 09:30 pm EST

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4,360.00JPY
Average target price
6,260.00JPY
Spread / Average Target
+43.58%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW